European Medicines Agency concludes insufficient data on use of inhaled corticosteroids to treat COVID-19
EMA’s COVID-19 taskforce has advised there is currently insufficient evidence that inhaled corticosteroids are beneficial for people with COVID-19. No safety risks were identified from studies so far, but it could not exclude possibility of harm in patients with normal O2 levels.
Source:
European Medicines Agency